Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Kaiser, T.
Right arrow Articles by Sawicki, P. T
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Should BP targets be lower in diabetic patients with microalbuminuria or nephropathy? A systematic review of randomised controlled trials

Thomas Kaiser

DIeM - Institute for Evidence Based Medicine, Cologne, Germany, t.kaiser{at}di-em.de, St. Franziskus Hospital, Cologne, Germany

Christiane Florack

DIeM - Institute for Evidence Based Medicine, Cologne, Germany

Uta Stephan

DIeM - Institute for Evidence Based Medicine, Cologne, Germany

Peter T Sawicki

DIeM - Institute for Evidence Based Medicine, Cologne, Germany, St. Franziskus Hospital, Cologne, Germany

Does antihypertensive treatment in normotensive patients with diabetic nephropathy alter the progression of kidney failure? We have evaluated studies of renal function which either assessed the effects of different therapeutic blood pressure (BP) goals, or the effects of antihypertensive therapy within the normotensive BP range. Need for renal replacement therapy was regarded as the most valid end point for assessment of deterioration of nephropathy, and change in the glomerular filtration rate (GFR) was regarded as a valid surrogate parameter. Five randomised controlled trials (RCTs) which included normotensive and hypertensive type 1 and type 2 diabetic patients have investigated the effect of lowering of BP within the normotensive range, or from hypertensive values to within the normotensive range. Albumin excretion in urine decreased in the groups randomised to lower BP values, but none of the trials demonstrated any beneficial effect of this intervention on the progression of kidney failure as assessed by the course of GFR. In conclusion, in diabetic patients with microalbuminuria or overt nephropathy, there is no evidence in the literature from RCTs for a beneficial effect of lowering BP within the normotensive range on the risk of kidney replacement therapy or on the loss of glomerular function.

Key Words: diabetic nephropathy • blood pressure • albuminuria • glomerular filtration rate • normotension • hypertension.

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 4, 278-281 (2003)
DOI: 10.1177/14746514030030040801
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?